← Eichor
Study identifier: NCT03667417 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation

Condition: Breast Cancers · Ovarian Cancers  ·  Sponsor: Institut Paoli-Calmettes

PhaseN/A
Planned participants5000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

Cohort of subjects carrying a BRCA gene mutation: genetic predispositions to breast and ovarian cancers

This description comes directly from the study's public registry record.

Talk to the study team

Dominique GENRE, MD  ·  33 491 22 37 78  ·  DRCI.UP@ipc.unicancer.fr

Margot BERLINE, MSc, MBA  ·  33 491 22 33 14  ·  DRCI.UP@ipc.unicancer.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Institut Paoli-CalmettesMarseille, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03667417